Attached files
| file | filename |
|---|---|
| 10-K - SRPT 12/31/2020 10-K - Sarepta Therapeutics, Inc. | srpt-10k_20201231.htm |
| EX-32.2 - EX-32.2 - Sarepta Therapeutics, Inc. | srpt-ex322_12.htm |
| EX-32.1 - EX-32.1 - Sarepta Therapeutics, Inc. | srpt-ex321_6.htm |
| EX-31.2 - EX-31.2 - Sarepta Therapeutics, Inc. | srpt-ex312_14.htm |
| EX-31.1 - EX-31.1 - Sarepta Therapeutics, Inc. | srpt-ex311_17.htm |
| EX-21.1 - EX-21.1 - Sarepta Therapeutics, Inc. | srpt-ex211_13.htm |
| EX-10.63 - EX-10.63 - Sarepta Therapeutics, Inc. | srpt-ex1063_752.htm |
| EX-10.62 - EX-10.62 - Sarepta Therapeutics, Inc. | srpt-ex1062_753.htm |
| EX-10.61 - EX-10.61 - Sarepta Therapeutics, Inc. | srpt-ex1061_755.htm |
| EX-10.60 - EX-10.60 - Sarepta Therapeutics, Inc. | srpt-ex1060_754.htm |
| EX-10.59 - EX-10.59 - Sarepta Therapeutics, Inc. | srpt-ex1059_751.htm |
| EX-10.58 - EX-10.58 - Sarepta Therapeutics, Inc. | srpt-ex1058_724.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Sarepta Therapeutics, Inc.:
We consent to the incorporation by reference in the registration statements (Nos. 333-209709, 333-234698 and 333-2229934) on Form S-3ASR and (Nos. 333-101826, 333-172823, 333-175031, 333-192287, 333-199037, 333-209710, 333-213022, 333-34047, 333-49994, 333-49996, 333-221271, 333-228719, 333-233715 and 333-240996) on Form S-8 of Sarepta Therapeutics, Inc. and subsidiaries of our report dated March 1, 2021, with respect to the consolidated balance sheets of Sarepta Therapeutics, Inc. and subsidiaries as of December 31, 2020 and 2019, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2020, and the related notes (collectively, the consolidated financial statements), and the effectiveness of internal control over financial reporting as of December 31, 2020, which report appears in the December 31, 2020 annual report on Form 10-K of Sarepta Therapeutics, Inc. and subsidiaries.
Our report refers to a change in the method of accounting for leases as of January 1, 2019 due to the adoption of Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842).
/s/ KPMG LLP
Boston, Massachusetts
March 1, 2021